We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.89B
AUM Growth
+$72.5M
Cap. Flow
+$60.2M
Cap. Flow %
3.19%
Top 10 Hldgs %
37.36%
Holding
2,292
New
978
Increased
275
Reduced
231
Closed
802

Sector Composition

Rank Sector Weight
1 Communication Services 23.21%
2 Financials 17.2%
3 Technology 13.4%
4 Healthcare 6.24%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCG icon
1126
Cheche Group
CCG
$34.7M
$60K ﹤0.01%
+1,948
New +$57.4K
VOR icon
1127
Vor Biopharma
VOR
$1.19B
$60K ﹤0.01%
+2,724
New +$45.1K
WWR icon
1128
Westwater Resources
WWR
$80.1M
$60K ﹤0.01%
85,116
+19,211
+29% +$11K
CTMX icon
1129
CytomX Therapeutics
CTMX
$758M
$59K ﹤0.01%
57,012
-31,506
-36% -$33.9K
EGY icon
1130
Vaalco Energy
EGY
$602M
$59K ﹤0.01%
+13,499
New +$71.7K
IHRT icon
1131
iHeartMedia
IHRT
$472M
$59K ﹤0.01%
30,010
+14,485
+93% +$30.7K
PANL icon
1132
Pangaea Logistics
PANL
$458M
$59K ﹤0.01%
+11,006
New +$66.3K
BIOA
1133
BioAge Labs
BIOA
$489M
$59K ﹤0.01%
+10,132
New +$175K
ELAB icon
1134
Elevai Labs
ELAB
$4M
$58K ﹤0.01%
+43
New +$224K
NOTE
1135
DELISTED
FiscalNote
NOTE
$58K ﹤0.01%
4,536
+1,469
+48% +$17.9K
PETS icon
1136
PetMed Express
PETS
$41.9M
$58K ﹤0.01%
+11,982
New +$56.1K
SONN
1137
DELISTED
Sonnet BioTherapeutics
SONN
$58K ﹤0.01%
+39,647
New +$138K
XBIT icon
1138
XBiotech
XBIT
$71.6M
$58K ﹤0.01%
+14,735
New +$100K
XERS icon
1139
Xeris Biopharma Holdings
XERS
$1.54B
$58K ﹤0.01%
+17,137
New +$55.1K
LYG icon
1140
Lloyds Banking Group
LYG
$89.5B
$57K ﹤0.01%
20,931
-163,898
-89% -$468K
BYND icon
1141
Beyond Meat
BYND
$210M
$56K ﹤0.01%
+14,848
New +$78.8K
CGTX icon
1142
Cognition Therapeutics
CGTX
$95.1M
$56K ﹤0.01%
80,180
+22,949
+40% +$11.3K
TOYO
1143
TOYO Co
TOYO
$241M
$56K ﹤0.01%
+16,613
New +$50.4K
OLPX
1144
DELISTED
Olaplex Holdings
OLPX
$55K ﹤0.01%
+31,658
New +$63K
QNCX icon
1145
Quince Therapeutics
QNCX
$32.2M
$55K ﹤0.01%
+146
New +$43.9K
AXTI icon
1146
AXT Inc
AXTI
$5.09B
$54K ﹤0.01%
+24,934
New +$56.6K
BRCC icon
1147
BRC Inc
BRCC
$215M
$54K ﹤0.01%
+17,031
New +$53.3K
CMND icon
1148
Clearmind Medicine
CMND
$2.45M
$54K ﹤0.01%
+99
New +$54.9K
JTAI icon
1149
Jet.AI
JTAI
$2.53M
$54K ﹤0.01%
+59
New +$130K
LAW icon
1150
CS Disco
LAW
$270M
$54K ﹤0.01%
+10,749
New +$62.4K

Similar funds

Virtu Financial's Q4 2024 Portfolio in Review

As of Q4 2024, Virtu Financial held 2,292 positions worth $1.89B, up 4% from $1.82B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Virtu Financial deployed $60.2M of net new capital in Q4 2024, opening 978 new positions and adding to 275 existing holdings. Its largest new stake was Apple: 75,436 shares worth $18.9M.

By sector, the portfolio is most concentrated in Communication Services at 23% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $206M trimmed.

  • Virtu Financial's largest Q4 2024 buy was Apple: 75,436 shares worth $18.9M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2024, an estimated $68.6M increase.
  • Virtu Financial's biggest Q4 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $206M.
  • Virtu Financial fully exited Strategy Inc in Q4 2024, selling an estimated $37.8M.
  • Virtu Financial's ten largest holdings make up 37% of its $1.89B portfolio in Q4 2024.
  • Virtu Financial opened 978 new positions and closed 802 in Q4 2024.
  • Virtu Financial's portfolio value rose 4% quarter-over-quarter to $1.89B.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.